JAM
MRNA icon

Jupiter Asset Management’s Moderna MRNA Stock Holding History

Jupiter Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,866
Closed -$506K – 641
2021
Q1 		$506K Buy
3,866
+1,761
+84% +$255K 0.01% 484
2020
Q4 		$220K Buy
+2,105
New +$213K ﹤0.01% 564

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Jupiter Asset Management's MRNA Position: Q2 2021 in Review

Jupiter Asset Management sold out of Moderna (MRNA) in Q2 2021, closing a stake of 3,866 shares — an estimated $506K sold.

Jupiter Asset Management first reported a position in MRNA in Q4 2020 and held it in 2 quarters. The position peaked at $506K in Q1 2021. 903 funds tracked by Wall St. Rank hold MRNA as of Q2 2021.

  • Jupiter Asset Management reported no remaining Moderna position as of Q2 2021 after selling out during the quarter.
  • Jupiter Asset Management sold 3,866 Moderna shares in Q2 2021, an estimated $506K.
  • Jupiter Asset Management first reported a position in Moderna in Q4 2020 and held it in 2 quarters.
  • Jupiter Asset Management's Moderna position peaked at $506K in Q1 2021.
  • 903 funds tracked by Wall St. Rank held Moderna as of Q2 2021.

Based on Jupiter Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.